Ticker Details
Gyre Therapeutics, Inc.
IPO Date:	August 21, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$661.11M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.29 | 3.76%
Avg Daily Range (30 D):	$0.22 | 2.84%
Avg Daily Range (90 D):	$0.19 | 2.45%

Institutional Daily Volume
Avg Daily Volume:	.75M
Avg Daily Volume (30 D):	.1M
Avg Daily Volume (90 D):	.07M

Trade Size
Avg Trade Size (Sh.):	440
Avg Trade Size (Sh.) (30 D):	63
Avg Trade Size (Sh.) (90 D):	67

Institutional Trades
Total Institutional Trades:	122
Avg Institutional Trade:	$1.59M
Avg Institutional Trade (30 D):	$1.52M
Avg Institutional Trade (90 D):	$1.52M
Avg Institutional Trade Volume:	.46M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.79M
Avg Closing Trade (30 D):	$1.52M
Avg Closing Trade (90 D):	$1.52M
Avg Closing Volume:	567.53K

News

Mar 12, 2026 @ 10:00 AM Gyre Therapeutics Reports Fourth Quarter and Full ... Source: Na

Nov 7, 2025 @ 11:00 AM Gyre Therapeutics Reports Third Quarter 2025 and Y... Source: Gyre Therapeutics

Oct 14, 2025 @ 11:00 AM Gyre Therapeutics to Present Results from Positive... Source: Prof. Lungen Lu, M.D.

Aug 22, 2025 @ 11:00 AM Gyre Therapeutics Announces the Appointment of Dan... Source: Gyre Therapeutics

Jun 10, 2025 @ 11:00 AM Gyre Therapeutics Announces First Dosing in Phase ... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.06	$-.02	$.06
Diluted EPS	$.02	$-.02	$.02
Revenue	$116.59M	$37.2M	$116.59M
Gross Profit	$111.17M	$35.45M	$111.17M
Net Income / Loss	$9.88M	$-1.37M	$9.88M
Operating Income / Loss	$11.49M	$.12M	$11.49M
Cost of Revenue	$5.42M	$1.74M	$5.42M
Net Cash Flow	$24.91M	$-3.46M	$24.91M
PE Ratio	369.50

Splits
Jan 13, 2023	2:1
Feb 13, 2017	1:15
Aug 21, 2015	1:7